Joseph K. Belanoff, CEO: Corcept Therapeutics CORT Sell · Filed 06/02

Trade details

Type: Insider sale
Amount: $895,252.38
Shares · price: 12,837 sh · $69.74 a share
Held after: 2,565,489 sh
Stock: Corcept Therapeutics CORT
Person: Joseph K. BelanoffCEO
Trade date: 26/06/01
Filed: 26/06/02
Days to filing: 1 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 05/02~07/01

Joseph K. Belanoff's recent trades

Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$892K
12,837 sh
$892K
Filed 06/01
Traded 06/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$2M
40,000 sh
$2M
Filed 05/05
Traded 05/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.9M
40,000 sh
$1.9M
Filed 05/01
Traded 05/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1.3M
26,198 sh
$1.3M
Filed 03/27
Traded 03/25
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.4M
40,000 sh
$1.4M
Filed 03/25
Traded 03/25